Smoking cessation for improving mental health.


Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
09 03 2021
Historique:
entrez: 9 3 2021
pubmed: 10 3 2021
medline: 22 4 2021
Statut: epublish

Résumé

There is a common perception that smoking generally helps people to manage stress, and may be a form of 'self-medication' in people with mental health conditions. However, there are biologically plausible reasons why smoking may worsen mental health through neuroadaptations arising from chronic smoking, leading to frequent nicotine withdrawal symptoms (e.g. anxiety, depression, irritability), in which case smoking cessation may help to improve rather than worsen mental health. To examine the association between tobacco smoking cessation and change in mental health. We searched the Cochrane Tobacco Addiction Group's Specialised Register, Cochrane Central Register of Controlled Trials, MEDLINE, Embase, PsycINFO, and the trial registries clinicaltrials.gov and the International Clinical Trials Registry Platform, from 14 April 2012 to 07 January 2020. These were updated searches of a previously-conducted non-Cochrane review where searches were conducted from database inception to 13 April 2012.  SELECTION CRITERIA: We included controlled before-after studies, including randomised controlled trials (RCTs) analysed by smoking status at follow-up, and longitudinal cohort studies. In order to be eligible for inclusion studies had to recruit adults who smoked tobacco, and assess whether they quit or continued smoking during the study. They also had to measure a mental health outcome at baseline and at least six weeks later. We followed standard Cochrane methods for screening and data extraction. Our primary outcomes were change in depression symptoms, anxiety symptoms or mixed anxiety and depression symptoms between baseline and follow-up. Secondary outcomes  included change in symptoms of stress, psychological quality of life, positive affect, and social impact or social quality of life, as well as new incidence of depression, anxiety, or mixed anxiety and depression disorders. We assessed the risk of bias for the primary outcomes using a modified ROBINS-I tool.  For change in mental health outcomes, we calculated the pooled standardised mean difference (SMD) and 95% confidence interval (95% CI) for the difference in change in mental health from baseline to follow-up between those who had quit smoking and those who had continued to smoke. For the incidence of psychological disorders, we calculated odds ratios (ORs) and 95% CIs. For all meta-analyses we used a generic inverse variance random-effects model and quantified statistical heterogeneity using I We included 102 studies representing over 169,500 participants. Sixty-two of these were identified in the updated search for this review and 40 were included in the original version of the review.  Sixty-three studies provided data on change in mental health, 10 were included in meta-analyses of incidence of mental health disorders, and 31 were synthesised narratively.  For all primary outcomes, smoking cessation was associated with an improvement in mental health symptoms compared with continuing to smoke: anxiety symptoms (SMD -0.28, 95% CI -0.43 to -0.13; 15 studies, 3141 participants; I Taken together, these data provide evidence that mental health does not worsen as a result of quitting smoking, and very low- to moderate-certainty evidence that smoking cessation is associated with small to moderate improvements in mental health.  These improvements are seen in both unselected samples and in subpopulations, including people diagnosed with mental health conditions. Additional studies that use more advanced methods to overcome time-varying confounding would strengthen the evidence in this area.

Sections du résumé

BACKGROUND
There is a common perception that smoking generally helps people to manage stress, and may be a form of 'self-medication' in people with mental health conditions. However, there are biologically plausible reasons why smoking may worsen mental health through neuroadaptations arising from chronic smoking, leading to frequent nicotine withdrawal symptoms (e.g. anxiety, depression, irritability), in which case smoking cessation may help to improve rather than worsen mental health.
OBJECTIVES
To examine the association between tobacco smoking cessation and change in mental health.
SEARCH METHODS
We searched the Cochrane Tobacco Addiction Group's Specialised Register, Cochrane Central Register of Controlled Trials, MEDLINE, Embase, PsycINFO, and the trial registries clinicaltrials.gov and the International Clinical Trials Registry Platform, from 14 April 2012 to 07 January 2020. These were updated searches of a previously-conducted non-Cochrane review where searches were conducted from database inception to 13 April 2012.  SELECTION CRITERIA: We included controlled before-after studies, including randomised controlled trials (RCTs) analysed by smoking status at follow-up, and longitudinal cohort studies. In order to be eligible for inclusion studies had to recruit adults who smoked tobacco, and assess whether they quit or continued smoking during the study. They also had to measure a mental health outcome at baseline and at least six weeks later.
DATA COLLECTION AND ANALYSIS
We followed standard Cochrane methods for screening and data extraction. Our primary outcomes were change in depression symptoms, anxiety symptoms or mixed anxiety and depression symptoms between baseline and follow-up. Secondary outcomes  included change in symptoms of stress, psychological quality of life, positive affect, and social impact or social quality of life, as well as new incidence of depression, anxiety, or mixed anxiety and depression disorders. We assessed the risk of bias for the primary outcomes using a modified ROBINS-I tool.  For change in mental health outcomes, we calculated the pooled standardised mean difference (SMD) and 95% confidence interval (95% CI) for the difference in change in mental health from baseline to follow-up between those who had quit smoking and those who had continued to smoke. For the incidence of psychological disorders, we calculated odds ratios (ORs) and 95% CIs. For all meta-analyses we used a generic inverse variance random-effects model and quantified statistical heterogeneity using I
MAIN RESULTS
We included 102 studies representing over 169,500 participants. Sixty-two of these were identified in the updated search for this review and 40 were included in the original version of the review.  Sixty-three studies provided data on change in mental health, 10 were included in meta-analyses of incidence of mental health disorders, and 31 were synthesised narratively.  For all primary outcomes, smoking cessation was associated with an improvement in mental health symptoms compared with continuing to smoke: anxiety symptoms (SMD -0.28, 95% CI -0.43 to -0.13; 15 studies, 3141 participants; I
AUTHORS' CONCLUSIONS
Taken together, these data provide evidence that mental health does not worsen as a result of quitting smoking, and very low- to moderate-certainty evidence that smoking cessation is associated with small to moderate improvements in mental health.  These improvements are seen in both unselected samples and in subpopulations, including people diagnosed with mental health conditions. Additional studies that use more advanced methods to overcome time-varying confounding would strengthen the evidence in this area.

Identifiants

pubmed: 33687070
doi: 10.1002/14651858.CD013522.pub2
pmc: PMC8121093
doi:

Banques de données

ClinicalTrials.gov
['NCT00689611', 'NCT02845687']

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

CD013522

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Références

Subst Abus. 2016 Oct-Dec;37(4):571-578
pubmed: 27093192
Psychol Med. 2014 Jan;44(1):127-41
pubmed: 23507203
NIDA Res Monogr. 1990;105:312-3
pubmed: 1876024
Clin Ther. 2001 Jun;23(6):957-69
pubmed: 11440295
J Clin Psychiatry. 2014 Jul;75(7):765-72
pubmed: 25006684
Exp Clin Psychopharmacol. 1999 Nov;7(4):427-43
pubmed: 10609977
BMC Public Health. 2015 Dec 29;15:1309
pubmed: 26714460
Ann Intern Med. 2013 Sep 17;159(6):390-400
pubmed: 24042367
Health Psychol. 1987;6(4):289-303
pubmed: 3301320
Am J Public Health. 2008 Mar;98(3):446-8
pubmed: 17600251
BMJ Open Respir Res. 2014 Aug 28;1(1):e000047
pubmed: 25478191
Nicotine Tob Res. 2011 Mar;13(3):209-14
pubmed: 21330275
J Bras Pneumol. 2015 Sep-Oct;41(5):433-9
pubmed: 26578135
World J Biol Psychiatry. 2003 Apr;4(2):49-55
pubmed: 12692774
Addiction. 2016 Sep;111(9):1536-53
pubmed: 27003925
Nicotine Tob Res. 2014 May;16(5):615-20
pubmed: 24353342
Neuroimage. 2011 Apr 15;55(4):1480-9
pubmed: 21281718
Eur J Public Health. 2011 Jun;21(3):347-54
pubmed: 20570962
Eur J Public Health. 2012 Apr;22(2):224-9
pubmed: 20884658
Allergy Asthma Immunol Res. 2010 Oct;2(4):254-9
pubmed: 20885910
Arch Gen Psychiatry. 1998 Feb;55(2):161-6
pubmed: 9477930
Ann Behav Med. 2012 Dec;44(3):309-19
pubmed: 22865499
PLoS One. 2019 Apr 8;14(4):e0214252
pubmed: 30958831
J Dual Diagn. 2017 Jul-Sep;13(3):168-178
pubmed: 28414583
Eur J Public Health. 2005 Jun;15(3):251-5
pubmed: 15905183
AIDS Patient Care STDS. 2007 Sep;21(9):659-66
pubmed: 17919093
Exp Clin Psychopharmacol. 2012 Apr;20(2):139-50
pubmed: 22039752
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Addiction. 2005 Mar;100(3):299-303
pubmed: 15733243
J Affect Disord. 2019 Sep 1;256:267-277
pubmed: 31195244
Drug Alcohol Depend. 2013 Feb 1;128(1-2):148-54
pubmed: 22995766
Scand Cardiovasc J. 2006 Feb;40(1):11-6
pubmed: 16448992
Trials. 2015 Feb 26;16:65
pubmed: 25885807
Addict Behav. 2019 Aug;95:206-210
pubmed: 30978583
Addict Behav. 2011 Dec;36(12):1228-32
pubmed: 21872401
Tob Control. 2017 Mar;26(2):195-201
pubmed: 27098008
J Psychiatr Res. 2011 Feb;45(2):143-9
pubmed: 20630542
Compr Psychiatry. 2015 Jul;60:142-8
pubmed: 25882595
Nicotine Tob Res. 2007 Mar;9(3):315-27
pubmed: 17365764
Ann Behav Med. 1995 Dec;17(4):331-8
pubmed: 24203600
J Am Geriatr Soc. 2015 Nov;63(11):2426-8
pubmed: 26603074
BMC Public Health. 2017 Jan 19;17(1):100
pubmed: 28103841
Psychol Med. 2020 Oct;50(14):2435-2443
pubmed: 31689377
Addict Behav. 1992 Nov-Dec;17(6):587-601
pubmed: 1488939
PLoS One. 2011;6(7):e21689
pubmed: 21818261
Qual Life Res. 2017 Sep;26(9):2387-2395
pubmed: 28429240
Am J Addict. 2014 Sep-Oct;23(5):459-65
pubmed: 24628943
Adicciones. 2010;22(4):317-24
pubmed: 21152850
BMC Psychiatry. 2015 Apr 14;15:83
pubmed: 25884648
AIDS Patient Care STDS. 2017 Feb;31(2):49-59
pubmed: 28170303
Nicotine Tob Res. 2014 Apr;16(4):413-22
pubmed: 24174612
Asia Pac J Public Health. 2012 Jan;24(1):82-90
pubmed: 21159694
BMJ. 2014 Feb 13;348:g1151
pubmed: 24524926
BMJ. 2004 Jun 26;328(7455):1519
pubmed: 15213107
N Engl J Med. 1997 Oct 23;337(17):1195-202
pubmed: 9337378
J Affect Disord. 1999 Oct;55(2-3):125-32
pubmed: 10628881
Addiction. 2010 Aug;105(8):1466-71
pubmed: 20528815
Psychol Addict Behav. 2009 Mar;23(1):67-76
pubmed: 19290691
Cochrane Database Syst Rev. 2021 Mar 9;3:CD013522
pubmed: 33687070
BMJ Open. 2015 May 07;5(5):e007249
pubmed: 25953727
Psychol Addict Behav. 2008 Mar;22(1):122-8
pubmed: 18298238
J Neurobiol. 2002 Dec;53(4):606-17
pubmed: 12436424
Biometrics. 2000 Jun;56(2):455-63
pubmed: 10877304
Can J Psychiatry. 2009 Mar;54(3):204-8
pubmed: 19321025
J Psychiatr Res. 2012 Apr;46(4):436-43
pubmed: 22277304
Cancer Causes Control. 2013 Oct;24(10):1849-63
pubmed: 23860953
Psychiatry Clin Neurosci. 2000 Apr;54(2):169-72
pubmed: 10803811
Qual Life Res. 2013 Aug;22(6):1381-9
pubmed: 23054494
Can J Public Health. 1994 Mar-Apr;85(2):99-102
pubmed: 8012927
BMC Public Health. 2019 Mar 6;19(1):267
pubmed: 30841877
Int J Behav Med. 2016 Apr;23(2):234-42
pubmed: 26475034
J Behav Med. 2006 Apr;29(2):151-60
pubmed: 16534659
Eur J Cancer. 2012 Jul;48(11):1593-601
pubmed: 22244802
Nicotine Tob Res. 2014 Feb;16(2):197-207
pubmed: 24057928
Nicotine Tob Res. 2020 Jan 27;22(1):18-23
pubmed: 30219867
Psychol Addict Behav. 2004 Dec;18(4):362-6
pubmed: 15631608
Addiction. 2006 Mar;101(3):362-72
pubmed: 16499509
AIDS Care. 2020 Oct;32(10):1217-1223
pubmed: 31847536
Health Qual Life Outcomes. 2017 Jan 3;15(1):1
pubmed: 28069015
Community Ment Health J. 2011 Dec;47(6):694-702
pubmed: 21556784
Nicotine Tob Res. 2015 Jun;17(6):735-41
pubmed: 25385874
J Subst Abuse Treat. 2015 Dec;59:104-8
pubmed: 26272693
J Womens Health (Larchmt). 2012 Feb;21(2):240-8
pubmed: 21992583
Drug Alcohol Depend. 2013 Dec 1;133(2):324-9
pubmed: 23896304
Chest. 2018 Aug;154(2):274-285
pubmed: 29476876
BMJ Open. 2019 Mar 23;9(3):e025124
pubmed: 30904860
Nicotine Tob Res. 2013 Nov;15(11):1807-15
pubmed: 23509093
J Abnorm Psychol. 2002 Nov;111(4):670-5
pubmed: 12428781
Addict Behav. 2015 Dec;51:93-9
pubmed: 26240944
N Engl J Med. 2010 Jun 17;362(24):2295-303
pubmed: 20554984
Ann Behav Med. 2012 Apr;43(2):262-70
pubmed: 22160762
Drug Alcohol Depend. 2019 Jan 1;194:173-177
pubmed: 30445275
Cogn Behav Neurol. 2012 Mar;25(1):16-24
pubmed: 22330182
Drug Alcohol Depend. 2015 Feb 1;147:76-80
pubmed: 25542824
Am J Public Health. 2007 Dec;97(12):2281-7
pubmed: 17971550
Drug Alcohol Depend. 2016 Aug 01;165:245-52
pubmed: 27372219
J Consult Clin Psychol. 1992 Oct;60(5):689-97
pubmed: 1401384
Nagoya J Med Sci. 2016 May;78(2):205-13
pubmed: 27303107
BMC Public Health. 2015 Nov 20;15:1150
pubmed: 26589146
Psychol Addict Behav. 2015 Dec;29(4):1041-7
pubmed: 25844830
Nicotine Tob Res. 2004 Oct;6(5):809-18
pubmed: 15700916
Addiction. 2012 Oct;107(10):1847-56
pubmed: 22429388
Neuropsychopharmacology. 2002 Jan;26(1):75-85
pubmed: 11751034
Prev Med. 2018 May;110:38-46
pubmed: 29427673
Nicotine Tob Res. 2002 Nov;4(4):433-9
pubmed: 12521402
Res Synth Methods. 2021 Jan;12(1):55-61
pubmed: 32336025
Eur J Cardiothorac Surg. 2011 Dec;40(6):1432-7; discussion 1437-8
pubmed: 21498082
J Behav Med. 2005 Aug;28(4):325-33
pubmed: 16049631
Zhonghua Nei Ke Za Zhi. 2016 Nov 1;55(11):854-858
pubmed: 27801340
J Psychoactive Drugs. 2019 Jan-Mar;51(1):48-57
pubmed: 30570409
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Behav Ther. 2016 Jan;47(1):54-65
pubmed: 26763497
J Popul Ther Clin Pharmacol. 2014;21(3):e346-56
pubmed: 25326910
Psychooncology. 2015 Sep;24(9):1012-9
pubmed: 25257853
PLoS One. 2016 Mar 01;11(3):e0150554
pubmed: 26930217
Am J Prev Med. 2004 Oct;27(3):258-60
pubmed: 15450640
Sleep Med. 2012 Oct;13(9):1130-7
pubmed: 22901402
J Psychosom Res. 2012 Sep;73(3):185-90
pubmed: 22850258
Drug Alcohol Depend. 2011 Mar 1;114(1):77-81
pubmed: 20951511
Bipolar Disord. 2012 Feb;14(1):99-108
pubmed: 22329477
Trials. 2012 Nov 13;13:207
pubmed: 23148822
Psychiatr Q. 2020 Jun;91(2):263-271
pubmed: 31845167
Drug Alcohol Depend. 2004 Dec 7;76(3):287-95
pubmed: 15561479
Trials. 2012 Aug 01;13:125
pubmed: 22852834
J Nucl Med. 2007 Nov;48(11):1829-35
pubmed: 17942810
J Bras Pneumol. 2009 May;35(5):436-41
pubmed: 19547852
Nicotine Tob Res. 2007 Mar;9(3):389-96
pubmed: 17365770
PLoS One. 2011;6(5):e19590
pubmed: 21611123
Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):493-500
pubmed: 26307130
Neuropsychopharmacology. 1999 Aug;21(2):195-202
pubmed: 10432467
J Affect Disord. 2020 Mar 1;264:76-81
pubmed: 31846904
J Clin Psychopharmacol. 2009 Dec;29(6):601-3
pubmed: 19910728
Qual Life Res. 2016 Mar;25(3):669-85
pubmed: 26310284
Addict Behav. 2017 Oct;73:9-15
pubmed: 28431293
Arch Gen Psychiatry. 1991 Jan;48(1):52-9
pubmed: 1984762
J Consult Clin Psychol. 2014 Feb;82(1):122-9
pubmed: 24219183
Lancet. 2017 May 13;389(10082):1885-1906
pubmed: 28390697
Addict Behav. 1979;4(4):345-8
pubmed: 525502
BMJ Open. 2015 Oct 21;5(10):e008774
pubmed: 26490099
Biol Psychiatry. 1998 Apr 1;43(7):525-30
pubmed: 9547932
Med J Aust. 2011 Aug 1;195(3):S7-11
pubmed: 21806523
Drug Alcohol Depend. 2019 Nov 1;204:107495
pubmed: 31491583
Nicotine Tob Res. 2006 Aug;8(4):581-9
pubmed: 16920656
J Anxiety Disord. 2015 Dec;36:92-8
pubmed: 26460537
Addict Behav. 2019 Mar;90:14-19
pubmed: 30352340
Am J Psychiatry. 1968 May;124(11):1580-4
pubmed: 5647023
Am J Psychiatry. 2000 Mar;157(3):368-74
pubmed: 10698811
Addiction. 2013 Feb;108(2):294-306
pubmed: 23072580
Lancet. 2013 Jan 12;381(9861):133-41
pubmed: 23107252
J Affect Disord. 2016 Feb;191:94-9
pubmed: 26655118
JAMA Psychiatry. 2013 May;70(5):522-33
pubmed: 23536105
Nicotine Tob Res. 2015 Mar;17(3):356-60
pubmed: 25180078
Qual Life Res. 2008 Dec;17(10):1217-27
pubmed: 18931942
Chest. 2004 Dec;126(6):1733-41
pubmed: 15596667
Addiction. 2014 Jul;109(7):1172-83
pubmed: 24690003
Neuropsychopharmacology. 2001 Apr;24(4):350-8
pubmed: 11182530
Health Psychol. 1990;9(4):466-78
pubmed: 2373070
AIDS Care. 2017 Jan;29(1):24-31
pubmed: 27435835
Pilot Feasibility Stud. 2019 Jan 22;5:16
pubmed: 30693096
BMC Public Health. 2012 Apr 04;12:271
pubmed: 22475087
Nicotine Tob Res. 2012 May;14(5):578-85
pubmed: 22058190
Psychooncology. 2017 Oct;26(10):1526-1534
pubmed: 27218657
Drug Alcohol Depend. 2014 May 1;138:67-74
pubmed: 24598122
J Clin Rheumatol. 2019 Oct;25(7):288-296
pubmed: 29994796
Psychiatry Res. 2016 Sep 30;243:407-12
pubmed: 27450743
Respir Care. 2015 Dec;60(12):1796-803
pubmed: 26286738
Contemp Clin Trials. 2018 May;68:127-132
pubmed: 29617633
Med Clin (Barc). 2008 Mar 29;130(11):405-9
pubmed: 18394364
PLoS One. 2016 Feb 04;11(2):e0147860
pubmed: 26845761
J Epidemiol. 2002 May;12(3):208-16
pubmed: 12164322
Tob Control. 2014 Jan;23(1):33-8
pubmed: 23111538
Adicciones. 2017 Sep 29;29(4):233-244
pubmed: 27749973
Addiction. 2010 Dec;105(12):2209-16
pubmed: 20840207
Pharmacotherapy. 2002 Jun;22(6):759-65
pubmed: 12066966
Nicotine Tob Res. 2009 Jun;11(6):707-14
pubmed: 19436040
Lancet. 2001 Jun 16;357(9272):1929-32
pubmed: 11425414
Addiction. 2016 Aug;111(8):1448-56
pubmed: 26918680
J Affect Disord. 2013 Jul;149(1-3):418-21
pubmed: 23265988
Psychiatr Serv. 2018 Mar 1;69(3):274-280
pubmed: 29137560
J Consult Clin Psychol. 1993 Oct;61(5):831-8
pubmed: 8245280
Health Psychol. 2002 Sep;21(5):438-43
pubmed: 12211510
Int J Environ Res Public Health. 2013 Jan 28;10(2):446-61
pubmed: 23358230
Br J Psychiatry. 2013 Jan;202(1):62-7
pubmed: 23284151
BMC Health Serv Res. 2014 Jul 14;14:304
pubmed: 25017205
J Consult Clin Psychol. 2002 Feb;70(1):142-52
pubmed: 11860040
J Posit Psychol. 2014 Jan 1;9(1):19-29
pubmed: 24683417
J Dual Diagn. 2012;8(2):117-125
pubmed: 22888309
Ann Behav Med. 2017 Feb;51(1):117-127
pubmed: 27670773
Can J Public Health. 1968 Apr;59(4):161-5
pubmed: 5651704
Przegl Lek. 2006;63(10):870-7
pubmed: 17288174
Nicotine Tob Res. 2017 Jan;19(1):68-76
pubmed: 27613888
Int J Public Health. 2019 Dec;64(9):1355-1365
pubmed: 31628523
Intern Med J. 2016 Sep;46(9):1089-96
pubmed: 27389637
Implement Sci. 2012 Sep 07;7:83
pubmed: 22958678
J Clin Epidemiol. 1992 Jul;45(7):769-73
pubmed: 1619456
Span J Psychol. 2017 Nov 20;20:E63
pubmed: 29153072
Lancet Psychiatry. 2019 Jan;6(1):25-34
pubmed: 30527763
Psychol Health Med. 2017 Oct;22(9):1127-1135
pubmed: 28103704
Int J Environ Res Public Health. 2009 Jan;6(1):310-20
pubmed: 19440285
Addict Behav. 2000 Mar-Apr;25(2):311-6
pubmed: 10795958
Addiction. 2009 May;104(5):850-8
pubmed: 19344444
Psychol Addict Behav. 2019 Mar;33(2):105-116
pubmed: 30614717
Addiction. 2009 May;104(5):719-33
pubmed: 19413788
Nicotine Tob Res. 2008 Nov;10(11):1609-20
pubmed: 18988073
J Addict Med. 2019 Jul/Aug;13(4):322-330
pubmed: 30664539
BMC Psychiatry. 2017 Apr 8;17(1):134
pubmed: 28390417
Addict Behav. 2013 Mar;38(3):1796-803
pubmed: 23254230
Prev Med. 2015 Apr;73:94-9
pubmed: 25655710
Nicotine Tob Res. 2018 Apr 2;20(5):575-582
pubmed: 28505303
J Gen Intern Med. 2009 May;24(5):563-9
pubmed: 19238488
J Health Psychol. 2018 Jul;23(8):1119-1128
pubmed: 27151069
Psychol Med. 2014 Sep;44(12):2523-35
pubmed: 25055171
Int J Psychiatry Med. 2006;36(4):413-26
pubmed: 17407995
Nicotine Tob Res. 2015 Apr;17(4):455-62
pubmed: 25762756
Nicotine Tob Res. 2018 Sep 4;20(10):1198-1205
pubmed: 29161451
J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):208-15
pubmed: 22732470
Acad Emerg Med. 2016 Jul;23(7):803-8
pubmed: 27146116
Exp Clin Psychopharmacol. 2015 Oct;23(5):351-60
pubmed: 26280589
Drug Alcohol Depend. 2019 Jan 1;194:128-135
pubmed: 30439609
Nicotine Tob Res. 2011 Feb;13(2):146-50
pubmed: 21106663
Am J Addict. 2006 Sep-Oct;15(5):336-44
pubmed: 16966189

Auteurs

Gemma Mj Taylor (GM)

Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.

Nicola Lindson (N)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Amanda Farley (A)

Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UK.

Andrea Leinberger-Jabari (A)

Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.

Katherine Sawyer (K)

Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.

Rebecca Te Water Naudé (R)

Medical Sciences Division, University of Oxford, Oxford, UK.

Annika Theodoulou (A)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Naomi King (N)

Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.

Chloe Burke (C)

Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.

Paul Aveyard (P)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH